Small Spleen Peptides (SSPs) Shape Dendritic Cell Differentiation through Modulation of Extracellular ATP Synthesis...

Area of Science:

• Immunology
• Biochemistry
• Dermatology

Background:

• Peripheral immune tolerance is critical for managing autoimmune diseases.
• The balance between extracellular ATP (exATP) and adenosine influences inflammation and tolerance.
• Small spleen peptides (SSPs) previously showed efficacy in inhibiting psoriatic arthritis by inducing tolerogenic dendritic cells (DCs) and regulatory T cells (Tregs).

Purpose of the Study:

• To investigate the mechanism by which SSPs regulate immune tolerance.
• To determine the role of exATP profiles in DC polarization towards inflammatory or tolerogenic states.
• To explore the therapeutic potential of SSPs in autoimmune conditions.

Main Methods:

• Identification of thymosins as key components of SSPs.
• Real-time measurement of exATP levels in DCs under different stimulation conditions.
• Assessment of SSPs' influence on adenosine receptors and in vivo psoriatic skin inflammation.

Main Results:

• Tolerogenic DC stimulation resulted in significant exATP synthesis and degradation, unlike immunogenic stimulation.
• SSPs, particularly thymosin-beta4 (Tβ4), were found to modulate exATP profiles.
• SSP administration inhibited psoriatic skin inflammation, mediated by adenosine receptors.

Conclusions:

• Contrasting exATP profiles are critical for DC polarization and immune tolerance.
• SSPs act as natural regulators of peripheral immune tolerance, with therapeutic potential for autoimmune diseases.
• Adenosine receptor signaling is a key pathway for the tolerogenic effects of SSPs.